Homocysteine
Homocysteine is an intermediate amino acid of methionine metabolism, linked for decades to cardiovascular and neurological risk — though how much lowering it actually reduces that risk remains a point of controversy in the literature.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — homocysteine is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
Homocysteine is an intermediate amino acid of methionine metabolism, linked for decades to cardiovascular and neurological risk — though how much lowering it actually reduces that risk remains a point of controversy in the literature.
- →Helps detect B-vitamin deficiency (B12, folate, B6), sometimes before megaloblastic anemia appears
- →Can be useful in the workup of unexplained, premature cardiovascular disease or venous thrombosis
- →Enables detection of rare inherited disorders of methionine metabolism at markedly elevated values
| Test type | Total plasma homocysteine concentration |
|---|---|
| Level of evidence | Moderate — a strong observational link to cardiovascular risk, but inconsistent evidence for causality and benefit from lowering it |
| Target group | People with premature cardiovascular disease, unexplained venous thrombosis, or suspected B12/folate deficiency |
| Key parameters | Total homocysteine concentration (μmol/L) |
| Preparation | Fasting (8–10 hours) recommended, along with avoiding intense physical exertion before the test |
| Status | A supplementary test, not a first-line screening test for the general population |
Understand
Overview
Homocysteine is a sulfur-containing amino acid formed as an intermediate product in methionine metabolism, an amino acid supplied mainly by animal protein. The test measures total plasma homocysteine concentration, usually fasting, and is ordered in the context of cardiovascular risk assessment, unexplained venous thrombosis, or suspected B-vitamin deficiency.
For years, numerous observational studies linked elevated homocysteine (hyperhomocysteinemia) to a higher risk of atherosclerosis, cardiovascular disease, and stroke, and early studies suggested that lowering it with folic acid and B-vitamin supplementation might reduce that risk. Later, large randomized clinical trials did not unequivocally confirm that lowering homocysteine alone translates into fewer cardiovascular events — this is partly explained by mandatory folic acid fortification of flour in some countries, which reduced the extent of baseline deficiency in the study populations. As a result, homocysteine's significance as an independent, modifiable risk factor remains a subject of scientific debate, and routine population-wide screening isn't universally recommended.
Who can genuinely benefit from this? People with premature cardiovascular disease or stroke without classic risk factors, unexplained venous thrombosis or recurrent miscarriage, and in the workup of vitamin B12 or folate deficiency when other parameters are ambiguous. A single elevated result rarely changes clinical management on its own — it's interpreted together with B12, folate status, and kidney function.
Mechanism of action
Homocysteine is formed in the methionine cycle during the transfer of methyl groups and must be removed through one of two metabolic pathways. The first is remethylation back to methionine, dependent on vitamin B12 (as a cofactor for methionine synthase) and folate (as a methyl-group donor), with an alternative pathway using betaine. The second is transsulfuration to cysteine, catalyzed by vitamin B6-dependent cystathionine beta-synthase. Deficiency in any of these vitamins, as well as genetic variants of the MTHFR enzyme, impair homocysteine clearance and lead to its accumulation in the blood.
Proposed mechanisms for the harmful vascular effects of elevated homocysteine include endothelial dysfunction through oxidative stress and reduced nitric oxide availability, increased proliferation of vascular smooth muscle cells, and prothrombotic effects through impacts on the coagulation cascade and platelet function. These mechanisms are biologically plausible and well documented at the cellular level, but — as more recent literature reviews emphasize — evidence from large interventional trials on actually lowering clinical risk remains inconsistent.
Formation of homocysteine in the methionine cycle
Homocysteine forms as an intermediate product of methyl-group transfer from methionine.
Remethylation dependent on B12 and folate
Vitamin B12 and folate enable the conversion of homocysteine back to methionine.
Transsulfuration dependent on vitamin B6
The alternative clearance pathway to cysteine requires vitamin B6 as a cofactor.
Evidence: moderate — based on 1 study in this database.
Benefits
Common myths
MythLowering homocysteine with B-vitamin supplementation always reduces the risk of heart attack or stroke.
FactLarge randomized clinical trials have not unequivocally confirmed that pharmacologically lowering homocysteine translates into fewer cardiovascular events, though it's still worth correcting genuine B-vitamin deficiencies if present.
MythElevated homocysteine always means a serious genetic disease.
FactThe most common cause of mildly elevated homocysteine is simple dietary vitamin B12 or folate deficiency, not rare inherited metabolic disorders like homocystinuria.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Reference ranges vary between labs, but values up to around 15 μmol/L are most often considered normal — higher results are classified as mild, moderate, or severe hyperhomocysteinemia, depending on how far above normal they are.
Supplementation makes sense with a confirmed deficiency of vitamin B12, folate, or B6, whereas routine supplementation solely to lower homocysteine in people without a deficiency hasn't shown a clearly confirmed cardiovascular benefit in clinical trials.
Not necessarily — the result can be temporarily raised by, among other things, not fasting before the test, dehydration, or recent intense exertion. A persistently elevated result is worth discussing with a doctor and supplementing with an assessment of B vitamins and kidney function.
What to combine with
Good combinations
Vitamin B12 — Elevated homocysteine often results from vitamin B12 deficiency — it's worth assessing both parameters together
Lipid Panel — When assessing cardiovascular risk, homocysteine is worth interpreting together with the lipid panel
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Deficiency of vitamin B12, folate, or vitamin B6 raises homocysteine levels
Kidney failure significantly raises the result regardless of vitamin status
Smoking and high coffee intake can temporarily raise the result
Certain medications (methotrexate, anticonvulsants, metformin) can affect homocysteine levels
Is it worth taking?
Who it's for
- People with premature cardiovascular disease or stroke without classic risk factors
- People with unexplained venous thrombosis, recurrent miscarriage, or suspected B-vitamin deficiency
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
Homocysteine is a natural intermediate product of methionine metabolism, an amino acid supplied mainly by animal protein.
Mandatory folic acid fortification of flour in some countries has lowered the average population homocysteine level, which made it harder for later clinical trials to demonstrate additional benefit from supplementation.
Studies
The review of the literature disclosed that there is a great controversy regarding the significance of homocysteine as a risk factor for cardiovascular disease and stroke.
Chrysant SG, Chrysant GS, Expert Review of Cardiovascular Therapy, 2018
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review
Moderate evidenceChrysant SG, Chrysant GS · Expert Review of Cardiovascular Therapy · 2018
A review of literature from 2010–2017 summarizing the evidence for homocysteine's link to cardiovascular risk and the controversy surrounding the benefit of lowering it pharmacologically.
View studySources & bibliography
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Serce i układ krążeniaEditorial team
VitMode Editorial — Heart and Circulation is the VitMode editorial team responsible for: the heart, blood pressure, lipids and cardiovascular prevention. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
75 publications on this site
Editorial review
Redakcja VitMode — Hormony i endokrynologiaEditorial team
VitMode Editorial — Hormones and Endocrinology is the VitMode editorial team responsible for: hormones, testosterone therapy, the thyroid and metabolism. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
328 publications on this site
Related entries
Vitamin B12
The only vitamin the body can store in the liver for years — yet its deficiency is often mistaken for dementia, depression or plain fatigue, because neurological changes can precede any abnormality in a standard blood count by years.
CRP and hs-CRP
A protein produced by the liver in response to inflammation — in its high-sensitivity form (hs-CRP) it has become one of the most widely studied additional markers of cardiovascular risk.
Lipid Panel
The lipid panel is one of the most important — and still one of the most frequently misread — preventive blood tests: 'total cholesterol' alone tells you less than the ratios between its fractions.
Metabolic Syndrome
A cluster of five risk factors — from abdominal obesity to elevated triglycerides — that multiplies the risk of type 2 diabetes and cardiovascular disease, but is largely modifiable through lifestyle change.
Methylation — why does it matter for health?
Methylation is one of the most fundamental biochemical processes in the body — gene expression, neurotransmitter synthesis, and liver detoxification all depend on it. It's also one of the most overused words in supplement marketing, where real, well-described biochemistry becomes the basis for promises that reach far beyond what studies actually support.
Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
Creatinine and eGFR (Estimated Glomerular Filtration Rate)
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
TSH and Thyroid Hormones (fT3, fT4, anti-TPO)
TSH is the first-line test for evaluating thyroid function, but on its own it rarely gives the full picture — only together with fT4, fT3, and anti-TPO can it distinguish a temporary fluctuation from an actual disorder.
Related articles
PoradnikiHigh Homocysteine Despite Normal B12 and Folate: What Next?
A blood test shows elevated homocysteine, while vitamin B12 and folate both come back normal. This happens more often than you'd think, and it doesn't mean the test is wrong — it means the cause lies somewhere else: genetics, vitamin B6, the kidneys, the thyroid, or a medication. We explain which of these leads are best supported by evidence and in what order it makes sense to check them.
October 3, 2026
PoradnikiB Vitamins (Folic Acid, B6, B12) and Cataracts — What a Large Trial in Women Showed
Folic acid, vitamin B6, and vitamin B12 are sometimes marketed as supporting eye health through antioxidant action and their effect on homocysteine levels. A large, randomized trial of nearly 4,000 women, run for over 7 years, found no protection against cataracts at all — and additionally showed a statistically significant increase in the risk of cataract surgery in the group taking these vitamins. This is a rare example of a supplement that not only failed to work, but may have actually caused harm.
August 27, 2026
Badania naukoweLongevity Vitamins: Which Supplements Actually Have Real Scientific Evidence Behind Them
Every supplement shelf promises a longer life in every capsule, but the hard data from large clinical trials tells a far more measured story. We go through which vitamins genuinely extend healthy lifespan in people with a real deficiency, and which — despite their popularity — have no supporting evidence at all, or worse, evidence of no benefit.
August 20, 2026
PoradnikiHormonal Birth Control and B6, B12, and Folate Deficiency
Combined hormonal contraceptives are taken by hundreds of millions of women worldwide and are considered one of the best-studied drug classes in medicine. Less often discussed is their long-term effect on the status of several B vitamins — especially B6, B12, and folate. A meta-analysis covering nearly 3,000 women found a significant drop in folate levels, and other systematic reviews confirm a similar, though usually moderate, pattern for B6 and B12. This has particular practical relevance at one specific moment: the period of planning a pregnancy after stopping birth control.
October 5, 2026
PoradnikiMethylfolate vs. Folic Acid: Which Form Is Right for Whom?
Supplement shelves and multivitamin labels increasingly push "methylfolate" as the default "better" form of vitamin B9, implying plain folic acid is outdated or even harmful. The biochemical truth is more nuanced: both forms have real differences, but which one actually matters for a given person depends on whether they have a genuine enzymatic conversion problem — and that applies to a far smaller group than marketing suggests.
October 15, 2026
PoradnikiNormal Testosterone, But You Feel Awful — Could You Still Have Hypogonadism?
A testosterone result that comes back "in range" on a lab printout doesn't always mean everything is hormonally fine — but it doesn't automatically mean you have hypogonadism either. We explain four real explanations for this mismatch, ranked by strength of evidence.
August 15, 2026
PoradnikiTRT or Natural Testosterone Boosting? A Practical Decision Test Before You Pick a Path
Before weighing the merits of TRT against the merits of lifestyle change, work out which of four situations you're actually in — because that, not preference or opinions from the internet, is what should decide your path.
August 15, 2026
PoradnikiTRT and High Estradiol — Symptoms, Causes, and What You Can Do About It
Suspect you have high estradiol on TRT? Before you reach for a forum post and someone else's anastrozole protocol, check which symptoms actually point to it and what order to act in — from bloodwork, through talking to your doctor, to a possible medication.
August 15, 2026